期刊
ADVANCED MATERIALS
卷 32, 期 24, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.202001452
关键词
chemodynamic therapy; ion exchange; metal-organic frameworks; photothermal therapy; Prussian blue nanoparticles; tumor therapy
类别
资金
- National Natural Science Foundation of China [51988102, 51690152, 51833007]
Nanotheranostic agents (NTAs) that integrate diagnostic capabilities and therapeutic functions have great potential for personalized medicine, yet poor tumor specificity severely restricts further clinical applications of NTAs. Here, a pro-NTA (precursor of nanotheranostic agent) activation strategy is reported for in situ NTA synthesis at tumor tissues to enhance the specificity of tumor therapy. This pro-NTA, also called PBAM, is composed of an MIL-100 (Fe)-coated Prussian blue (PB) analogue (K2Mn[Fe(CN)(6)]) with negligible absorption in the near-infrared region and spatial confinement of Mn2+ ions. In a mildly acidic tumor microenvironment (TME), PBAM can be specifically activated to synthesize the photothermal agent PB nanoparticles, with release of free Mn2+ ions due to the internal fast ion exchange, resulting in the ON state of both T-1-weighted magnetic resonance imaging and photoacoustic signals. In addition, the combined Mn2+-mediated chemodynamic therapy in the TME and PB-mediated photothermal therapy guarantee a more efficient therapeutic performance compared to monotherapy. In vivo data further show that the pro-NTA activation strategy could selectively brighten solid tumors and detect invisible lymph node metastases with high specificity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据